Health - Gastroenterology latest news

AMDL, a leading vertically integrated bio-pharmaceutical company with operations in China and the US, announced today the US Food and Drug Administration (FDA) has issued a letter of substantial equivalence to an existing predicate device and granted clearance to market the AMDL-ELISA DR-70® (FDP) as a safe and effective blood test for monitoring patients who have been previously diagnosed with colorectal cancer (CRC).

First-in-Class Treatment set to Provide a New and Important Targeted Treatment for Distressing and near Universal Side Effect in patients Receiving Opioids for Pain Relief as Part of Palliative Care Wyeth Pharmaceuticals, announced that it has received EMEA marketing approval for Relistor(TM) (methylnaltrexone bromide) subcutaneous injection.